674 related articles for article (PubMed ID: 18853456)
41. A unique intronic splicing enhancer controls the inclusion of the agrin Y exon.
Wei N; Lin CQ; Modafferi EF; Gomes WA; Black DL
RNA; 1997 Nov; 3(11):1275-88. PubMed ID: 9409619
[TBL] [Abstract][Full Text] [Related]
42. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
[TBL] [Abstract][Full Text] [Related]
43. Outcome of donor splice site mutations accounting for congenital afibrinogenemia reflects order of intron removal in the fibrinogen alpha gene (FGA).
Attanasio C; David A; Neerman-Arbez M
Blood; 2003 Mar; 101(5):1851-6. PubMed ID: 12406899
[TBL] [Abstract][Full Text] [Related]
44. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
[TBL] [Abstract][Full Text] [Related]
45. Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome.
King K; Flinter FA; Nihalani V; Green PM
Hum Genet; 2002 Dec; 111(6):548-54. PubMed ID: 12436246
[TBL] [Abstract][Full Text] [Related]
46. Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotides.
Aartsma-Rus A; Janson AA; Heemskerk JA; De Winter CL; Van Ommen GJ; Van Deutekom JC
Ann N Y Acad Sci; 2006 Oct; 1082():74-6. PubMed ID: 17145928
[TBL] [Abstract][Full Text] [Related]
47. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
Zatkova A; Messiaen L; Vandenbroucke I; Wieser R; Fonatsch C; Krainer AR; Wimmer K
Hum Mutat; 2004 Dec; 24(6):491-501. PubMed ID: 15523642
[TBL] [Abstract][Full Text] [Related]
48. Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.
Lisowiec J; Magner D; Kierzek E; Lenartowicz E; Kierzek R
RNA Biol; 2015; 12(3):330-42. PubMed ID: 25826665
[TBL] [Abstract][Full Text] [Related]
49. Genetic interactions between the 5' and 3' splice site consensus sequences and U6 snRNA during the second catalytic step of pre-mRNA splicing.
Collins CA; Guthrie C
RNA; 2001 Dec; 7(12):1845-54. PubMed ID: 11780639
[TBL] [Abstract][Full Text] [Related]
50. Molecular diagnosis of Stickler syndrome: a COL2A1 stop codon mutation screening strategy that is not compromised by mutant mRNA instability.
Freddi S; Savarirayan R; Bateman JF
Am J Med Genet; 2000 Feb; 90(5):398-406. PubMed ID: 10706362
[TBL] [Abstract][Full Text] [Related]
51. Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for x-linked dilated cardiomyopathy.
Rimessi P; Fabris M; Bovolenta M; Bassi E; Falzarano S; Gualandi F; Rapezzi C; Coccolo F; Perrone D; Medici A; Ferlini A
Hum Gene Ther; 2010 Sep; 21(9):1137-46. PubMed ID: 20486769
[TBL] [Abstract][Full Text] [Related]
52. A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease.
Di Leo E; Panico F; Tarugi P; Battisti C; Federico A; Calandra S
Hum Mutat; 2004 Nov; 24(5):440. PubMed ID: 15459971
[TBL] [Abstract][Full Text] [Related]
53. Analysis of exonic mutations leading to exon skipping in patients with pyruvate dehydrogenase E1 alpha deficiency.
Cardozo AK; De Meirleir L; Liebaers I; Lissens W
Pediatr Res; 2000 Dec; 48(6):748-53. PubMed ID: 11102541
[TBL] [Abstract][Full Text] [Related]
54. Intronic mutation in the PGK1 gene may cause recurrent myoglobinuria by aberrant splicing.
Shirakawa K; Takahashi Y; Miyajima H
Neurology; 2006 Mar; 66(6):925-7. PubMed ID: 16567715
[TBL] [Abstract][Full Text] [Related]
55. A deep intronic mutation in the RB1 gene leads to intronic sequence exonisation.
Dehainault C; Michaux D; Pagès-Berhouet S; Caux-Moncoutier V; Doz F; Desjardins L; Couturier J; Parent P; Stoppa-Lyonnet D; Gauthier-Villars M; Houdayer C
Eur J Hum Genet; 2007 Apr; 15(4):473-7. PubMed ID: 17299438
[TBL] [Abstract][Full Text] [Related]
56. SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D.
Caputi M; Zahler AM
EMBO J; 2002 Feb; 21(4):845-55. PubMed ID: 11847131
[TBL] [Abstract][Full Text] [Related]
57. NSSRs/TASRs/SRp38s function as splicing modulators via binding to pre-mRNAs.
Fushimi K; Osumi N; Tsukahara T
Genes Cells; 2005 Jun; 10(6):531-41. PubMed ID: 15938712
[TBL] [Abstract][Full Text] [Related]
58. An LKB1 AT-AC intron mutation causes Peutz-Jeghers syndrome via splicing at noncanonical cryptic splice sites.
Hastings ML; Resta N; Traum D; Stella A; Guanti G; Krainer AR
Nat Struct Mol Biol; 2005 Jan; 12(1):54-9. PubMed ID: 15608654
[TBL] [Abstract][Full Text] [Related]
59. A Novel Mutation in the Fibrinogen Bβ Chain (c.490G>A; End of Exon 3) Causes a Splicing Abnormality and Ultimately Leads to Congenital Hypofibrinogenemia.
Taira C; Matsuda K; Arai S; Sugano M; Uehara T; Okumura N
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156616
[TBL] [Abstract][Full Text] [Related]
60. Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements.
Bruno IG; Jin W; Cote GJ
Hum Mol Genet; 2004 Oct; 13(20):2409-20. PubMed ID: 15333583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]